Specifically, dysregulation of STAT3 and SIN3A activity during specific developmental stages may inhibit the expression of critical genes involved in differentiation processes, including CTTNBP2 and MCF2L, potentially contributing to NB pathogenesis. This evidence concerns the gene CTTNBP2 and neuroblastoma.